Sign in
4

Changes in Ownership

Fulcrum Therapeutics, Inc. Filed Acc 0001104659-19-040966

Options or other derivatives

  • Chief Operating Officer acquired 28,571 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Stuart Bryan Chief Operating Officer 2019-07-18 Grant or award · Stock Option (right to buy) +28,571 28,571 D: show line 1 in the form
Loading xslF345X03/a4.xml…